4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000040
Chief Accounting Officer acquired 18,290 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mossler Mark · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-14 | Grant or award : show line 1 in the form | +18,290 | 19,790 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-14 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +27,430 | 27,430 | D |
Loading xslF345X05/wk-form4_1712780190.xml…